Article
Investigation of NRXN1 deletions: clinical and molecular characterization.
American journal of medical genetics. Part A - 1 Apr 2013
Dabell Mindy Preston, Rosenfeld Jill A, Bader Patricia, Escobar Luis F, El-Khechen Dima, Vallee Stephanie E, Dinulos Mary Beth Palko, Curry Cynthia, Fisher Jamie, Tervo Raymond, Hannibal Mark C, Siefkas Kiana, Wyatt Philip R, Hughes Lauren, Smith Rosemarie, Ellingwood Sara, Lacassie Yves, Stroud Tracy, Farrell Sandra A, Sanchez-Lara Pedro A, Randolph Linda M, Niyazov Dmitriy, Stevens Cathy A, Schoonveld Cheri, Skidmore David, MacKay Sara, Miles Judith H, Moodley Manikum, Huillet Adam, Neill Nicholas J, Ellison Jay W, Ballif Blake C, Shaffer Lisa G
Abstract excerpt
Deletions at 2p16.3 involving exons of NRXN1 are associated with susceptibility for autism and schizophrenia, and similar deletions have been identified in individuals with developmental delay and dysmorphic features. We have identified 34 probands with exonic NRXN1 deletions following referral for clinical microarray-based comparative genomic hybridization. To more firmly establish the full phenotypic spectrum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
